Fulltext

Serological evidence of human granulocytic ehrlichiosis in Switzerland

Pusterla, N. ; Weber, R. ; Wolfensberger, C. ; Schär, G. ; Zbinden, R. ; Fierz, W. ; Madigan, J. ; Dumler, J. ; Lutz, H.

In: European Journal of Clinical Microbiology and Infectious Diseases, 1998, vol. 17, no. 3, p. 207-209

Zum persönliche Liste hinzufügen
    Titel
    • Serological evidence of human granulocytic ehrlichiosis in Switzerland
    Autor
    • Pusterla, N.. Department of Veterinary Internal Medicine, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland
    • Weber, R.. Division of Infectious Diseases and Hospital Epidemiology, Department of Internal Medicine, University Hospital of Zurich, CH-8091, Zurich, Switzerland
    • Wolfensberger, C.. Department of Veterinary Internal Medicine, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland
    • Schär, G.. Department of Medical Microbiology, University of Zurich, CH-8028, Zurich, Switzerland
    • Zbinden, R.. Department of Medical Microbiology, University of Zurich, CH-8028, Zurich, Switzerland
    • Fierz, W.. Institute of Clinical Microbiology and Immunology, CH-9000, St. Gallen, Switzerland
    • Madigan, J.. School of Veterinary Medicine, University of California, 95616, Davis, California, USA
    • Dumler, J.. Department of Pathology, The Johns Hopkins University School of Medicine, 21287, Baltimore, Maryland, USA
    • Lutz, H.. Department of Veterinary Internal Medicine, University of Zurich, Winterthurerstrasse 260, CH-8057, Zurich, Switzerland
    Dokumententyp
    • Postprint
    Sprache
    • Englisch
    Veröffentlicht in
    • European Journal of Clinical Microbiology and Infectious Diseases, 1998, vol. 17, no. 3, p. 207-209. Springer-Verlag
    Andere elektronische Ausgabe
    OAI-PMH-ID
    • oai:doc.rero.ch:315077
    Summary
    To investigate whether human granulocytic ehrlichiosis (HGE) is prevalent in Switzerland, 1515 human serum samples from individuals with different risks for tick exposure were tested for antibodies toEhrlichia phagocytophila, a surrogate marker of the agent of HGE. The distribution of titres showed marked differences between sera of individuals with no or low risk for tick exposure and those with a high risk. The results of serological testing provided evidence of HGE in Switzerland as well as evidence of two types of coinfections: those with the agent of HGE andBorrelia burgdorferi, and those with the agent of HGE and the central European tickborne encephalitis virus